Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Azithromycin Versus Intramuscular Penicillin for Secondary Prevention of Rheumatic Heart Disease in Nigerian Secondary School Students: A Comparative Study to Improve Outcomes in Rheumatic Heart Disease Management

NCT07625228 is registered in ClinicalTrials.gov with Ladoke Akintola University of Technology, Ogbomoso, Nigeria as lead sponsor.

NCT NCT07625228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07625228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Azithromycin Versus Intramuscular Penicillin for Secondary Prevention of Rheumatic Heart Disease in Nigerian Secondary School Students: A Comparative Study to Improve Outcomes in Rheumatic Heart Disease Management
Lead sponsor
Ladoke Akintola University of Technology, Ogbomoso, Nigeria
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 5, 2027
Completion date
December 30, 2031
Enrollment
474 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatic fever, valvular cardiomyopathy, valvular heart diseases